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Abstract 
The performance demands of dental care products reflect the importance of healthy teeth over the entire span of human life. One 
approach towards the prevention of dental hypersensitivity, tooth demineralisation and dental caries involves the use of 
polymeric dental coatings that block dentinal tubules (a key mechanistic strategy in the treatment of dentine hypersensitivity), 
provide a barrier to the acid-mediated demineralisation of enamel, and also inhibit the bacterial colonisation of teeth. This paper 
presents the physicochemical principles that govern the molecular design of such polymeric-coating treatments. 
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Introduction 
Dental caries is considered to be the most common 
form of chronic disease among children, accounting for 
the majority of hospitalisations for those of primary 
school age.
(1)
 In adults, untreated tooth decay is seen in 
ca. 30% of people aged 35 – 44 and in ca. 20% of 
people over 65.
(2)
 The pioneering bacterial colonisers 
are primarily Streptococci, representing 47 – 85% of 
the cultivable cells from rinses following tooth 
brushing.
(3,4)
 The attachment of the pioneer species is 
followed by colonisation with increasing proportions of 
Actinomyces, and the consequential progression of 
plaque to a mature bacterial community that contains 
high levels of Gram-negative anaerobic filamentous 
organisms
(5)
 that are embedded within a biofilm. It is 
the acidic bacterial metabolites of plaque that are 
responsible for the onset of dental caries: the localised 
chemical dissolution of dental hard tissues by acidic by-
products from metabolic events taking place within the 
biofilm.
(6)
 Once plaque is established, the continuous 
production of acid metabolites distorts the acid/base 
equilibrium of the demineralisation/remineralisation 
process, which, owing to the presence of water amongst 
the hydroxyapatite (HA) microcrystals, is not limited to 
the tooth surface.
(7)
 Electron acceptor H
+
 ions diffuse 
into the bulk of the tooth effecting the dissolution of 
Ca
2+ 
and phosphate ions into the aqueous phase, which, 
if this process is undisrupted, results in the formation of 
cavities.
(8)
 The principal aetiological species in tooth 
caries is S. mutans:
(9)
 in addition to its capability to 
grow and survive in low pH environments, this 
organism produces highly erosive lactic acid on 
metabolising dietary carbohydrates and  also converts 
dietary sugars to glucan polymers that contribute to the 
formation of the plaque biofilm.
(9)
 
 
Bacterial adhesion: physicochemical considerations 
Bacteria adhere readily to surfaces for survival and 
propagation. Generally, this brings about the formation 
of an adherent layer (biofilm, dental pellicle) composed 
of bacteria embedded in an organic matrix. The biofilm 
matrix is primarily a glycoprotein (the exopolymer), 
which is generated by the bacteria and may contain 
matter that is derived from the environment. Usually, 
bacterial adhesion is promoted by the formation of a 
conditioning layer. Once colonisation has been 
achieved, the formation and subsequent growth of the 
bacterial biofilm are largely independent of the 
substrate. A sequence of four phases is involved: (i) 
transport of bacteria to the surface; (ii) reversible 
attachment of bacteria to that surface – van der Waals 
interactions overcome repulsive electrostatic forces; 
(iii) development of specific interactions involving 
chemical bonding develop between the bacterium and 
the substrate, and (iv) colonisation of the surface and 
formation of a bacterial biofilm. 
The initial adhesion of microorganisms to a surface 
is influenced by long-range and short-range forces. The 
nature of interactions may be considered to be governed 
by the same rules as those that dictate the aqueous 
stability of colloidal particles;
(10)
 even though bacteria 
are far from ideal particles, having neither simple 
geometry nor a simple uniform molecular 
composition.
(11)
 
Prerequisite to the bacterial colonisation of dental 
surfaces is the adherence of a colonising organism onto 
the target surface.
(12)
 Dependent upon the interaction of 
the aqueous medium with the surface addressed by 
colonising bacteria, one of two physico-chemical 
approaches may be employed to describe the 
mechanism of initial attachment. The interaction 
between hydrophilic surfaces and bacteria are best 
explained by the thermodynamic approach, whereas the 
DLVO theory-based approach is more readily applied 
to lipophilic surfaces.
(13,14)
 It is axiomatic to both 
approaches that surface properties that minimise the 
initial adsorption processes would also make the 
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substrate unattractive for the direct attachment of 
colonising organisms. 
 
Dental erosion 
In addition to the mechanical tooth-wear processes 
(attrition, tooth-to-tooth wear, and abrasion wear from 
externally applied particles or objects),
(15)
 dental 
surfaces are routinely challenged by erosive tooth wear 
(dental erosion; the loss of dental hard tissue through 
chemical etching by acids or chelating agents of non-
bacterial origin).
(16)
 Apart from the extrinsic causes of 
tooth demineralisation that are commonly associated 
with the consumption of acidic beverages,
(16)
 intrinsic 
demineralisation – resulting from the effects of gastric 
acid reaching the teeth as a result of vomiting, gastro-
oesophageal reflux, rumination, or from impaired 
remineralisation mechanisms due to insufficient saliva 
production or from calcium deficiency – is also 
common.
(16)
 
Dependent upon its pKa, acid within the aqueous 
environment of the mouth dissociates to produce H
+ 
ions which attack the tooth mineral
(17)
 and dissolve it by 
interacting with the CO3
2-
 and PO4
3-
 groups of HA (Eq. 
1)
(17)
 which in turn leads to surface etching. 
Ca10-x Nax (PO4)6-y (CO3)z (OH)2-u Fm + 3H
+
 
→ (10-x)Ca2+ + xNa+ + (6-y)(HPO4
2-
)  + z(HCO3
-
) + 
H2O + mF
-
    (Eq. 1) 
Many of the hydroxy organic acids that are 
abundant in fruit and vegetable products (mainly citric 
acid and malic acid) are capable of attacking teeth.
(18)
 
Beverages can also contain citric acid: respective 
concentrations in drink juices, orange and lemon juice 
are ca. 0.3, 1 and 6%.
(19)
 Lactic acid, commonly formed 
as a result of the natural fermentation of dairy, meat and 
some pickled products, is also capable of attacking 
teeth. 
There is a strong body of evidence to suggest that 
the excessive consumption of acidic foods and drinks 
pose a risk to dental hard tissues.
(20)
 In 2007, the 
worldwide annual consumption of soft drinks reached 
552 billion L, the equivalent of just under 83 L person
-1
 
y
-1
. By 2009, average consumption in the US had 
reached 212 L person
-1
 y
-1
.
(20)
 While the minimisation 
of the amount of sugar in soft drinks to reduce the 
formation of plaque-bacteria-derived organic acids is 
now a commercial reality,
(21)
 the projected significant 
reduction in the erosive potential of soft drinks 
consequent to a possible increase in the typical pH from 
ca. 3.3 to ca. 4.0,
(22)
 is impeded by associated 
compromises in the taste and microbial stability of the 
product.
(23)
 An alternative strategy that has received 
considerable interest involves the enrichment of acidic 
drinks with Ca
2+
,
(24)
 which functions by chelating a 
proportion of the available citric acid. For example, 
adding Ca
2+
 (0.0198 g/100 mL) to citric acid (0.24 
g/100 mL) at pH 3.8 has been shown to reduce enamel 
dissolution by 50%.
(25)
 Kolahi et al. have suggested that 
tooth friendly soft drinks may be formulated by 
incorporating fluoride at a concentration of ca. 1 – 1.2 
ppm.
(26)
 Another approach towards the reduction of the 
erosive potential of soft drinks involves the use of 
matrix metalloproteinase (MMP) inhibitors,
(27)
 as 
exemplified by the work of Barbosa et al.
(28)
 and Kato 
et al.
(29)
 who investigated the supplementation of soft 
drinks with natural MMP inhibitors from green tea 
extracts. 
 
The demineralisation and remineralisation of 
enamel 
Each time teeth are exposed to plaque or food 
acids, the natural demineralisation-remineralisation 
equilibrium that is integral to the health of the entire 
tooth becomes distorted. The effects of 
demineralisation may be manifested as: surface 
softening (removal of minerals is limited to a depth of 1 
– 10 µm), caused by short-term exposure to acid in food 
and beverages at pH 2 – 4; subsurface demineralisation 
(depth of lesions in the range 20 – 1000 µm), induced 
by dental plaque acids maintaining a long-term pH of 
4.5 – 6.5; surface etching (irreversible tissue loss), 
caused by prolonged exposure to strong acid.
(30)
 
Natural remineralisation is a carbonic acid-
mediated equilibrium process that occurs as HA crystal 
growth through the deposition of calcium and 
phosphorus compounds at the surface of teeth.
(31)
 The 
transport of these minerals is driven by the gradient of 
decreasing concentration that exists between the 
biofilm/saliva and the aqueous phase of dental HA.
(32)
 
The presence of plaque or food acids, distorts the 
equilibrium in favour of demineralisation, but the 
process is normally reversible if adequate recovery time 
is allowed between acid challenges.
(32)
 The mechanism 
of remineralisation is influenced by the degree of 
demineralisation. In the case of surface softening, 
enamel remineralisation has been suggested to involve 
a seeded growth of HA-like material in which an 
amorphous calcium phosphate (ACP) phase loses water 
to form crystalline HA (ACP  octacalcium phosphate, 
OCP  HA) .(33) Lesion remineralisation is believed to 
proceed via the direct deposition of HA onto the 
growing crystal. The presence of F
-
, even at the 1 ppm 
level, has a twofold effect upon the remineralisation 
process: it increases the deposition rate by a factor of 2 
– 3, and results in the simultaneous formation of 
fluorohydroxyapatite (FHAP), which is a material less 
susceptible to demineralisation than biological HA.
(30,34)
 
 
The effect of saliva on enamel demineralisation and 
remineralisation 
The importance of saliva in dental health is 
signified by the simple observation that the relative 
susceptibility of teeth to erosive agents is dependent 
upon their position within the oral cavity: dental erosion 
is most commonly observed on the palatal surfaces of 
the upper teeth, which are poorly bathed in saliva, while 
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erosion is less common on lingual surfaces of the lower 
teeth, which are constantly bathed in saliva.
(35,36)
 
Stimulation of salivary flow aids the re-deposition 
of calcium and phosphorus onto demineralised surfaces 
and increases the buffering capacity of the saliva. 
Magalhães et al.,
(37)
 who reviewed preventative 
measures for patients with increased risk for erosion, 
have documented that saliva stimulated by the use of 
sugar-free chewing gum promotes remineralisation, and 
that the consumption of certain PO4
3-
- and Ca
2+
-rich 
foods (milk or cheese) are beneficial since these bestow 
salivary proteins (statherin) with the high 
concentrations of Ca
2+
 and PO4
3-
 that are essential to the 
remineralisation process.
(37)
 
The salivary pellicle is integral to the natural tooth-
protection mechanism, as demonstrated from 
comparative surface-microhardness measurements on 
pellicle-coated and pellicle-free enamel specimens that 
had been exposed to erosive acid.
(38)
 As expected, the 
protective effect of the pellicle layer against the erosive 
influence of organic acids is reported to be controlled 
by the duration of the acid treatment and by the 
concentration of the erosive agent.
(39)
 An inverse 
relationship has also been reported between the 
thickness of the acquired pellicle and the degree of 
erosion.
(37)
 An investigation on the origins of the 
protective effect of the in situ pellicle on dentin erosion 
has led to the suggestion that the pellicle functions 
mainly as an ion-permeable network, rather than as a 
protective barrier.
(40)
 
Studies on the remineralisation of carious lesions 
have shown that early stage enamel surface 
demineralisation is reversible, but no conclusive 
evidence has been presented as yet regarding the 
dominant mechanisms governing the remineralisation 
of softened enamel and that of dental lesions.
(41)
 An in 
vitro study examined the time element of the artificial 
saliva-induced remineralisation process of citric acid-
softened enamel: within the time limits imposed by the 
experimental protocol, remineralisation is reported to 
have affected the partial re-hardening of enamel, but to 
have failed to restore the original surface structure.
(41)
 
The composition of the remineralisation medium is 
important, however, as is exemplified by the work of 
Lippert et al.
(42)
 who demonstrated the significance of 
trace elements, such as Zn and Sr, in promoting 
remineralisation. 
 
Dentin hypersensitivity 
Dentin hypersensitivity (DH) is characterised by 
short sharp pain arising from exposed dentin in 
response to stimuli (typically thermal, evaporative, 
tactile, osmotic or chemical) that cannot be ascribed to 
any other dental defect or disease.
(43)
 DH can occur on 
all tooth surfaces but is predominantly localised at the 
cervical part of the buccal surface,
(44)
 normally as a 
result of the exposure of dentinal tubules subsequent to 
loss of enamel or due to gingival recession.
(45)
 
Discomfort from tooth hypersensitivity is common, 
with a considerable proportion of the adult population 
experiencing it at some point in their lifetime.
(46)
 The 
pain associated with DH is mediated by dental nerve 
terminals that respond to the displacement of the liquid 
content of dentinal tubules:
(47)
 a pain provoking 
stimulus applied to dentin increases the flow of dentinal 
tubular fluid, activating the nerves situated at the inner 
ends of the tubules or at the outer layers of the pulp.
(43)
 
The permeation of substances across dentin may occur 
by diffusion or by convection. The driving force for 
diffusion is a concentration gradient (chemical potential 
energy) whereas that for convective transport is 
movement of bulk fluid, which in turn is induced by 
differences in hydraulic pressure.
(48)
 SEM imaging has 
shown that sensitive teeth have ca. 8 times as many 
open tubules at the surface as non-sensitive teeth and 
that those tubules are larger, as a result of the 
progressive loss of dentin.
(49)
 On the basis of the 
hydrodynamic theory, approaches that involve a 
decrease in tubular diameter represent the most widely 
used strategy for the management of tooth sensitivity. 
 
Staining 
Tooth colour, which varies from tooth to tooth, is 
determined by the combined effects of intrinsic colour 
(light absorption properties of enamel and dentin) and 
the presence of any extrinsic stains (adsorption of 
chromogens onto the pellicle coated tooth surface). In 
general, mandibular anterior teeth appear more lightly 
coloured than maxillary anterior teeth. Also, lateral 
incisors and canines appear more lightly coloured than 
maxillary central incisors. Teeth become discoloured 
with age: as dental pulp shrinks, it becomes darker and 
adopts a more yellow colouration. In addition, with 
increasing age, dentin becomes less permeable and 
harder, promoting the deposition of ions that permeate 
the layer of enamel.
(50)
 
Extrinsic staining has been linked to smoking, 
tooth-brushing technique, consumption of coloured 
foods (red wine, tea), the use of cationic medications 
(the most well-known being chlorhexidine, CHX) and 
the deposition of certain metal ions such as those of Sn 
or Fe. Many individuals are dissatisfied with their tooth 
colour,
(51)
 making whitening toothpastes the fastest 
growing sector of the oral hygiene market.
(52)
 Many 
whitening dentrifices help to reduce staining by the use 
of abrasives within the product (for the mechanical 
removal of the pellicle and dental stains), while others 
contain chemical constituents that reduce staining either 
via the inhibition of their deposition or by stain-
removal. Chemicals that have been evaluated for their 
potential to either lighten or desorb existing stains 
include surfactants, enzymes, Ca
2+
 chelating builders 
and calcium phosphate adsorbants.
(53)
 Tooth staining 
may be evaluated using visual inspection, stain guides, 
colourimetry, spectrophotometry and by the computer-
facilitated analysis of digital images. 
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Strategies for preventing the build-up of dental 
plaque 
The most commonly used method for disrupting 
plaque maturation (regular mechanical disruption by 
tooth brushing) is insufficient to achieve complete 
removal of plaque, especially in interdental and 
crevicular areas where complementary professional 
mouth cleaning is often needed.
(54)
 Mechanical brushing 
may also be complemented by antimicrobial agents. It 
has been demonstrated that a 99% reduction in bacterial 
counts is required before a 6 h delay in the onset of 
plaque formation can be achieved.
(55)
 In addition to 
having acceptable taste and possessing good oral 
substantivity, antibacterial agents must be non-toxic 
and must exhibit a broad spectrum of antibacterial 
activity, such that the oral ecology is not disturbed.
(55)
 
Alternative approaches to chemical treatment with 
antimicrobial agents include the use of quorum-sensing 
inhibitors or the deployment of biocompatible polymers 
as barriers to plaque build-up by creating a non-
permanent tooth shield. Central to the performance 
demands of such coatings are the capability of the 
polymer to form a continuous film, and the in vivo 
substantivity of that film. 
 
Adsorbed antimicrobial agents 
Amongst the several classes of antimicrobials that 
have been identified (Fig. 1),
(57)
 the poly-cationic 
biocides have been used extensively in mouth rinses, 
lozenges, sprays and gels.
(57)
 Of particular interest in 
dental care is cetylpyridinium chloride (CPC), which 
readily adsorbs onto enamel
(58)
 and also diffuses 
through the exopolysaccharide (EPS) component of the 
salivary pellicle to exert its antibacterial action by 
destroying the cytoplasmic membrane.
(59)
 Effective oral 
formulations of CPC include nanoemulsions,
(60)
 
resins,
(61)
 and orthodontic adhesives.
(62)
 The dental-care 
benefit of CPC was also confirmed by Moran et al. 
whose investigations into the activity of benzalkonium 
chloride (BAC; 0.1% and 0.05%) concluded that this 
material was not as effective an antiplaque agent as 
CPC or CHX.
(57)
 However, BAC has been suggested to 
be a useful antimicrobial for incorporation into 
orthodontic resins.
(63) 
 
 
Fig. 1: (a) General structure of quaternary ammonium compounds,  (b) cetylpyridinium chloride (CPC), (c) 
benzalkonium chloride (BAC; n = 7, 9, 11, 13, 15 or 17), (d) CHX, (e) hexetidine (HEX), (f) delmopinol, (g) 
triclosan (TC), (h) PEG, (i) poly(sulphobetaine), (j) poly(carboxybetaine).
(56)
 
 
CHX, a surfactant bis (biguanide), is a cationic 
antimicrobial that has been successfully used in 
dentistry for over 50 years owing to its proven 
effectiveness in inhibiting the development of plaque, 
and hence caries and gingivitis.
(64,65) 
The 
pharmaceutical industry recognises CHX as the gold 
standard against which anti-plaque agents may be 
measured.
(66)
 CHX functions by binding to negatively 
charged regions in the membrane of microorganisms, 
often phospholipids of the inner membrane, inducing to 
exposed microbes loss of osmotic flow, leakage of 
intracellular components and coagulation of the 
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proteins in the cytoplasm.
(67,68)
 The clinical efficacy and 
long-term bactericidal effects of CHX are further 
enhanced by good oral substantivity that stems from an 
affinity for adsorption onto HA.
(69)
 in a fashion that 
does not block the active sites of the agent.
(67)
 The  
usefulness of CHX extents from mouth rinses to gels, 
controlled release formulations,
(70)
 varnishes,
(64)
 and  
coatings (Fig. 2).
(71)
 The dental-care benefits of CHX 
are however counterbalanced by the undesirable effects 
of tooth staining, formation of calculus
(72)
 and bitter 
taste. In an effort to suppress these effects, Menegon et 
al. prepared a hydrophilic tetra-cation salt of CHX 
palmitate, which when formulated with poly(vinyl 
pyrrolidone) was claimed not to exhibit the undesirable 
side effects of CHX.
(73)
 In a separate effort, Solis et al. 
employed patients with chronic periodontitis to 
demonstrate the improved clinical efficiency of CHX 
mouthwash with an incorporated anti-discoloration 
system (composed of ascorbic acid, and sodium 
metabisulphite).
(74) 
 
The broad spectrum antiseptic pyrimidine
(75)
 
derivative hexetidine (HEX),
(76)
 which exhibits a lower 
tendency to cause tooth staining than CHX is also of 
value in the formulation of dental-care products.
(75,77)
 
The efficacy of HEX is amenable to amplification by 
metal ions, as is exemplified by the synergistic effect 
against Streptococcus mutans observed in the presence 
of Zn
2+
 .
(78)
  
 
Fig. 2: (a) %Bacterial adhesion (mean ± sem) to Ti (control, 100%), Ti / poly(benzyl acrylate) PBA and Ti / 
PBA-0.35 after immersion in phosphate-buffered-saline (PBS) for 48 h and then in the culture medium for 2 
days; (b) structure of PBA; (c) %CHX release from the Ti / PBA-0.35 coating in PBS (37 °C). Adapted from 
(71)
 and used with permission. 
 
Delmopinol, an aminoalcohol, is another molecule 
that combines significant substantivity with antiplaque 
properties.
(79)
 Its mechanism of action involves the 
inhibition of pellicle formation
(80)
 and the consequent 
reduction in the number of bacteria in the pellicle and 
plaque matrix.
(81)
 Since delmopinol is not as powerful a 
stain chromogen as CHX, Addy et al. proposed the use 
of its mouthwash formulations as an adjunct measure 
for the prevention of plaque and gingivitis.
(81)
 
An active that is free of known side effects is 
triclosan (5-chloro-2-(2,4-dichlorophenoxy)phenol; TC; 
Fig. 1),
(82)
 a chlorinated diphenyl ether that exhibits a 
broad spectrum of activity against Gram-positive 
bacteria, including Streptococcus mutans. The primary 
limitations of TC are its low aqueous solubility (< 10 
µg mL
-1
)
(8)
 and its limited affinity for plaque or oral 
tissues, with the implication that its oral concentration 
is not readily sustainable at levels sufficient to effect 
the treatment of dental caries.
(83)
 Of significance in the 
development of improved oral formulations of TC has 
been the patented (1990) discovery that poly(vinyl 
methylether-co-maleic acid) – a  dual-function polymer 
in which the carboxyl group acts as a tooth-anchoring 
moiety and the methoxyether groups provides a 
solubilising matrix for triclosan – increases the 
retention of TC in the oral cavity. Kockisch et al. 
demonstrated the controlled-release behaviour of TC-
loaded chitosan microspheres,
(84)
 while Loftsson et al. 
utilised a cyclodextran matrix for the same purpose.
(85)
 
Fe et al. developed a mineral-binding micellar drug 
delivery system of alendronate and pluronics that is 
reported to not only inhibit biofilm formation but also  
reduce the viability of preformed biofilms.
(9)
 Another 
alternative dosage form for the improved delivery of 
TC has utilised fast-dissolving films of hydroxypropyl-
β-cyclodextrin and poloxamer.(86) It is now widely 
accepted that the twice-a-day use of TC copolymer 
toothpastes can give clinically significant 
improvements in plaque control and gingivitis and may 
slow the progression of periodontal disease.
(87)
 
The coupling of antimicrobials to biopassive 
polymers has also been considered (Fig. 3).
(88,89)
 A 
comparative study of antibacterial films of 
poly(methylmethacrylate-co-methacrylic acid) and 
poly(methylmethacrylate-co-
trimethylaminoethylmethacrylate chloride) found that 
both types of material are promising antifouling surface 
treatments, in that the negatively charged polymer 
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delays the onset of biofilm formation while the 
positively charged macromolecule acts by inhibiting 
bacterial proliferation.
(90) 
Despite their inherent anti-bacterial properties, the 
value of Ag coatings in effecting a reduction of 
bacterial adhesion has been the subject of some 
debate.
(91)
 Nonetheless, the addition of microparticulate 
Ag to resin composite material has been shown to 
increase resistance to bacterial colonisation and to 
produce bactericidal effects
(92)
 while complexes of Ag 
and perfluorodecanethiolate have been shown to exhibit 
antifouling and antibacterial properties.
(93)
 
 
 
Fig. 3: Schemes illustrating the immobilisation of antimicrobial coatings to actively kill any bacteria that 
adhere to the surface: (a) with pertinent examples highlighted from the literature; (b) antimicrobial polymer 
based on quaternary ammonium compound; (c) structure of synthesised antimicrobial poly(2-methyl-2-
oxazoline) (PMOX) with acrylate polymerisable end group and N,N-dimethyldodecylammonium (DDA); (d 
and e) preparation of contact-active antimicrobial coating from an aqueous polymer suspension of 
hydrophobic poly(styrene) block (PS) and hydrophilic block of antimicrobial polymer poly(4-vinyl-N-
methylpyridinium iodide) (P4VMP); (e) polymeric particles obtained using PS/P4VMP as the emulsifier 
shown via blue circles. Adapted from 
(88)
 and used with permission. 
 
Natural Extracts 
Driven by consumer demand, and in view of the 
issues of increasing microbial resistance to 
conventional antibiotics, many researchers have 
attempted evaluations of natural products, as is 
exemplified by studies on honey derived from the 
flowers of the Manuka tree (Leptospermum scoparium, 
New Zealand). Badet and Quero
(94)
 and independently 
Nassar
(95)
 have suggested oral-health benefits of such 
products by demonstrating that Manuka honey is 
capable of inhibiting the formation of a biofilm of S. 
mutans. Nayak et al., following their comparative study 
of CHX, xylitol chewing gums and Manuka honey, 
concluded that this honey is an effective inhibitor of 
plaque formation.
(96)
 More viable alternatives to 
conventional antimicrobials are provided by chitosan 
and essential oils.
(97)
 Tea-tree oil has received 
considerable attention for its broad spectrum 
antibacterial activity
(98)
 and because of its documented 
growth-inhibiting effects on cariogenic bacteria and its 
anti-adherence effects on S. mutans.
(99)
 Essential oil 
mouth rinses
(100)
 have been claimed to offer oral-care 
benefits that are similar to those of CHX
(98)
 or CPC
(101)
 
with no alteration of basic salivary parameters.
(102)
 
Chitosan, a product derived from the deacetylation of 
chitin, has been shown to exhibit antimicrobial 
properties against oral bacteria and to be capable of 
altering the physico-chemical properties of the 
pellicle.
(103)
 Water-soluble (reduced) chitosan has been 
shown to have a potent effect against S. mutans and to 
exhibit plaque-reducing action.
(104)
 These findings have 
underpinned the development of a chitosan-containing 
polyherbal toothpaste.
(105)
 
 
Quorum sensing inhibitors 
The use of quorum-sensing inhibitors is an 
evolving concept that may prove of value in inhibiting 
the formation of oral biofilm.
(106)
 Since the discovery 
that quorum sensing in S. mutans biofilm growth is 
primarily regulated by the competence stimulating 
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peptide (CSP) and the ComD/ComE two-component 
signal transduction system, attempts have been made to 
develop therapeutic or preventative agents against 
dental caries.
(107)
 Early work suggested that the use of 
CSP at high concentrations is capable of effecting 
growth arrest and eventual cell death in S. mutans,
(107)
 
but considerable research developments are needed 
before this approach can be considered for clinical 
applications. 
 
Inhibiting bacterial adhesion onto tooth surfaces: 
the non-toxic approaches 
The initial adhesion of bacteria to a surface is 
influenced by both the chemistry of the addressed 
surface and the aqueous environment surrounding that 
surface. In the oral environment, the colonisation of 
dental surfaces is influenced by the interplay of factors 
that include the chemistry, charge and roughness of the 
tooth surface, and also by the nature of the acquired 
pellicle, which is in turn is at least in part influenced by 
the dietary intake and habits of the individual. Towards 
the inhibition of bacterial adhesion to surfaces, three 
non-toxic coating approaches have been evolved: (1) 
the hydrophilic approach, (2) low-surface-energy 
approach, and the (3) mobile-polymeric-surface 
approach.
(108)
 
 
Hydrophilic approach 
The most widely employed strategy towards 
preventing the attachment of bacteria (B) and proteins 
from an aqueous environment (W) onto a surface (S) 
involves the pre-adsorption of a hydrophilic 
macromolecular chain. The approach is underpinned by 
consideration of the free energy of adhesion (Eq. 2): 
∆Gads = −(γSB − γSW − γBW)  (Eq. 2)  
where  = interfacial free energy between substrate (S), 
bacteria (B) and water/media (W). For an unprotected 
surface, bacteria would become strongly attached (Eq. 
3), 
γSB >  γSW + γBW   (Eq. 3) 
and the adsorption of proteins would also be 
favourable. The protective layer, an ultra-thin coating 
of a polymeric amphiphile, presents a hydrated surface 
to the liquid phase, so that the adsorption of proteins 
and other molecules involves the displacement of 
adsorbed water. Although this would give an increase 
in entropy, the enthalpy requirement for the desorption 
of strongly-bound water molecules is much more 
significant at the physiological temperature and the 
process is unfavourable Gads > 0 (or much less 
favourable, Gads < 0, but small). A kinetic barrier may 
also be introduced, inhibiting the adsorption process 
even if it is thermodynamically favourable. Similarly, 
the attachment of bacteria to the surface is not favoured 
because it would be accompanied by a decrease in the 
value of Gads, as S-W and B-W interfaces are replaced 
by S-B interfaces. Thus, bacterial and other biofouling 
may be avoided by preparing a formulation from which 
a polymeric amphiphile can become available for 
adsorption onto enamel in a manner that allows: (a) the 
less hydrophilic component of the surfactant to anchor 
to the surface and (b) the more hydrophilic component 
to extend into the aqueous phase. 
Poly (ethylene glycol)s (PEGs) and their congeners 
are the materials of choice for such applications. These 
polymers offer a high degree of hydration (> 80% w/w) 
and a water interfacial energy of < 5 mJ m
-2
.
(109)
 The 
immobilisation of these polymers onto the surface may 
be achieved either through physisorption or via the 
controlled covalent coupling of appropriately 
functionalised derivatives to anchoring surface groups 
.
(109,110)
 The free energy change associated with 
binding/adsorption involves both enthalpic and entropic 
contributions, but, for PEGs in aqueous media at 
physiologically relevant temperatures (37 C), the 
competing, entropic term becomes of little significance 
(the enthalpic term dominates up to ca. 85 C.(111) 
The simplest method for the attachment of 
hydrophilic/amphiphilic polymers to a surface is by 
encouraging adsorption through the adjustment of the 
hydrophilic/hydrophobic balance of a (co) polymer 
according to the nature of the addressed surface. Since 
it is prerequisite to dental applications that the adsorbed 
polymer be substantive, the fouling-resistant polymer 
may be mixed with a second, priming, polymeric 
component that facilitates anchoring at the tooth surface 
by virtue of its compatibility with both the non-
hydrophilic segments of the functional polymer and the 
tooth surface. Although several methods are available 
for the chemical grafting of hydrophilic polymers onto 
surfaces, the value of the approach to dental care has 
yet to be assessed. 
Since the grafting density
(112)
 and chain length of 
PEGs
(113,114)
 are critically important in determining the 
efficiency of a coating at preventing protein and 
bacterial adhesion, the so called polymer brushes 
(polymers that adhered to a target solid surface), are the 
subject of considerable research.
(112,115)
 Olsson et al. 
have shown that poly(alkylene oxide) derivatives 
inhibit the binding of S.mutans to non-pelicilised 
hydroxyl apatite.
(116)
 This study, and also independent 
work by Saldarriaga Fernandez et al.
(117)
 established 
that, owing to the favourable association of salivary 
mucins with PEG chains, the presence of saliva renders 
PEG coatings less effective at inhibiting bacterial 
colonisation. Shimotoyodome et al. found that 
mouthwash formulations of methacryloxydecyl 
phosphate-PEG and pyrophosphate are capable of 
preventing dental biofilm formation.
(118)
 Consequently, 
alternative bioinert polymers including polysaccharides, 
non-ionic, zwitterionic and peptidomimetic compounds 
are being investigated.
(111,119)
 Among the zwitterionic 
polymers,
(120)
  sulphobetaines
(121)
 have been found to be 
effective anti-adherent coatings to biofouling. Polymer 
brushes synthesised from carboxybetaine polymers are 
expected to be effective low-fouling surface modifiers 
Sarah J. Upson et al.                                                                                            Polymeric Coatings for Dental Care 
Journal of Pharmaceutical and Biological Sciences, 2017; 5(6):227-243                                                                234 
in different biological environments in inhibiting 
protein adsorption.
(120)
 Poly(sulphobetaine) and 
poly(carboxybetaine) have been found reported to 
reduce the formation of biofilms from both Gram-
positive and Gram-negative bacteria (Fig. 4).
(122,123) 
 
Fig. 4: Self-assembled monolayer thiol structures / polymers on Au coated glass (via a Cr adhesion layer) and resultant 
representative fluorescence microscopy images showing Pseudomonas aeruginosa attachment after 24 h exposure. 
Adapted from (122) and used with permission. 
 
It is long established that sugars and other bacteria-
fermentable dietary carbohydrates are erosive-acid-
generating substrates that play a major role in the 
aetiology of dental caries.
(124)
 Sugar substitutes have 
been widely investigated for their effect in limiting the 
dietary sources of caries hazards.
(125)
 Xylitol, a five-
carbon sugar alcohol that has a similar taste to sucrose, 
represents one of the most extensively studied sugar 
substitutes
(8)
 since the majority of plaque bacteria are 
incapable of fermenting xylitol into cariogenic acid 
products
(126)
 xylitol is converted by oral bacteria to the 
glycolysis inhibitor xylitol 5-phosphate.
(2)
 It has been 
claimed that xylitol chewing gum augments the 
buffering effect of saliva by increasing salivary flow,
(2)
 
and also reduces the counts of S. mutans in plaque and 
saliva.
(127) 
 
Long-range forces of adhesion: the DLVO theory 
The DLVO theory of colloid stability may be used 
to describe the combination of the long-range forces 
that are responsible for the adhesion of microorganisms 
to the tooth surface.
(13,14)
 Accordingly, the stability of 
the adsorbed state is determined by the sum of the 
potential energies that are associated respectively with 
the attractive van der Waals forces and the repulsive 
electrostatic forces (electrical double layer) that operate 
as a microorganism approaches the surface due to 
Brownian motion. 
The electrostatic repulsion potential VR between a 
plane surface and a sphere at separation x, due to 
relatively thin electrical double layers, is of the form 
(Eq. 4)
(128)
 
VR = P ln(1 + e
−qx)   (Eq. 4) 
where the constant P contains the zeta potential and the 
particle radius, and q is the inverse of the double-layer 
thickness. For this system, the attractive van der Waals 
interactions become relatively long-range (Eq. 5): 
VA = −
S
x
    (Eq. 5) 
where the constant S contains the polarizabilities of the 
surface atoms of the interacting bodies. The individual 
potentials, the total potential V (Eq. 6): 
V = VR + VA     (Eq. 6) 
and the corresponding force of attraction F (Eq. 7): 
F =
S
x2
−
Pqe-qx
1+e-qx
    (Eq. 7) 
are shown as a function of x in Fig. 5. The attractive 
van der Waals interactions begin to pull the bacterium 
towards the surface at nanoscale distances that are 
determined by the bacterial species, the nature of the 
surface and the aqueous medium. Since under most 
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physiological conditions, bacterial surfaces carry a net 
negative charge and most natural surfaces are also 
negatively charged, significant electrostatic repulsion 
occurs at somewhat shorter distances. This gives rise to 
a potential minimum (point ‘B’ in Fig. 5) at a 
separation of a few nanometres, which corresponds to a 
weakly adsorbed state (cf. the flocculated state of a 
colloid). In this state, the bacterium is readily displaced 
from the surface. A closer approach involves 
overcoming an energy barrier (‘A’ in Fig. 5) leading to 
an extremely low ‘primary’ potential minimum, not 
shown, at ca. 1 nm from the surface. The large force of 
adhesion at the primary minimum renders the 
adsorption irreversible. 
Fig. 5: Illustration of the (a) potential energy V and (b) force of attraction F between a bacterium and a plane 
surface as functions of separation x, as described using DLVO theory, drawn using equations (Eq. 4 – 7) with 
P = 1, q = 5 and S = 0.05.
(56)
 
 
The strength of the repulsive interactions is 
determined by the density of the negative charges on 
the interacting surfaces and by the ionic strength of the 
medium.
(129,130)
 If electrostatic repulsions are large and 
the energy barrier is high then the secondary minimum  
 
 
may not occur, and/or the formation of the strongly 
adsorbed state may be slow. If, however, electrostatic 
repulsions are reduced (electrolytic neutralisation of 
surface charges) then the potential barrier will be  
 
 
lowered and the strongly adsorbed state will be formed 
rapidly and irreversibly.
(129)
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Consistent with the observation that plaque 
accumulation starts at pits and grooves, studies 
designed to examine the relative contributions of 
surface roughness and surface energy with respect to 
susceptibility to bacterial colonisation have concluded 
that above a threshold value of approximately the same 
size as that of the bacterial colonisers
(131)
 accumulation 
of plaque is encouraged irrespective of the energy of 
the surface.
(132,133)
 
 
Low-surface-energy polymers 
Interest in the low-surface-energy approach dates 
back to the early 1980s following the observation that 
gorgonian corals, which have low energy surfaces, are 
not susceptible to colonisation by marine 
microorganisms.
(134)
 It is now established that the main 
molecular-design requirement for low surface energy 
polymer coatings is a flexible linear backbone onto 
which are attached pendant chains exhibiting low 
intermolecular interactions (aliphatic hydrocarbon or 
preferably perfluorocarbon; Table 1).
(135,136) 
 
Table 1: Surface free energies (20 C) of films 
prepared from common polymers.
(56)
 
Polymer Surface free energy 
/ mJ m-2 
Polyamide-6,6; nylon 47 
Poly(ethylene glycol); PEG 43 
Poly(styrene) 41 
Poly(ethene) 34 
Poly(trifluoroethene) 24 
Poly(dimethylsiloxane); Silicone 21 
Poly(tetrafluoroethene); Teflon 18 
Poly(1H,1H,2H,2H-
perfluorododecyl (meth)acrylate) 
6 
 
Weerkamp et al. demonstrated that lowering the 
surface free energy to below 60 mJ m
-2
 could retard 
plaque accumulation on smooth surfaces by inhibiting 
bacterial adhesion.
(131)
 Tsibouklis et al. demonstrated 
that two classes of low surface energy polymers, 
namely poly(methylpropenoxyfluoroalkyl siloxane)s 
and poly(perfluoro (meth)acrylate)s, possessed good 
resistance against a range of bacterial and yeast 
colonisers.
(134) 
The same group has shown that films of 
poly(perfluoro (meth)acrylate)s that had been deposited 
onto human enamel from aqueous emulsions hold 
considerable promise as substantive dental barriers.
(137)
 
Zhao et al. also found the surface energy of coatings to 
have a significant influence on bacterial adhesion and 
calculated the optimum surface energy components of 
substrates for minimising adhesion to E. coli, 
Staphylococci epidermidis and Streptococci adhesion in 
water (Fig. 6).
(91) 
 
 
Fig. 6: Optimum surface free energy components of 
substrates for minimising (a) E. coli and (b) 
Staphylococci epidermidis adhesion in water. 
Adapted from 
(91)
 and used with permission. 
 
In their comparative study of a hydrophylic and a 
hydrophobic material, Lassen et al. found that PEG-co-
poly(ethylene imine) was more susceptible to 
colonisation by S. mutans than a hydrophobic surface 
of plasma-polymerised hexamethyldisiloxane.
(138)
 
 
Mobile surface polymers 
Typified by thick films of silicone-oil-fortified 
silicones, another strategy for preventing cell adhesion 
involves the use of materials that present a highly 
mobile surface. The near zero barrier to rotation of the 
siloxane (-SiO-) backbone
(139)
 and the inherent low 
surface energy of the material renders it a useful 
antifoulant.
(140-142)
 Although films of these materials 
have found extensive uses in marine-antifouling 
applications, their performance within the oral 
environment may be limited by their thickness. 
Strategies to reduce dental erosion 
 
Fluorides 
Dependent upon the level of F
-
 in drinking water, 
healthy sub-surface enamel contains F
-
 at ca. 20 – 100 
ppm while the outer few µm of enamel may reach 
levels in the range 1000 – 2000 ppm.(143) The most 
convenient access to fluoridated medicaments is 
through the over-the-counter availability of dentifrices 
and rinses. The levels of F
-
 contained in these are 
dictated by the anti-caries monographs of regulatory 
agencies. In the absence of a specific anti-erosion 
monograph, and given the concerns for fluorosis 
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associated with the use of higher levels of F
-
 in 
children, technologies that augment the anti-erosion 
efficacy of medicaments containing F
-
 at current 
concentrations (900–1500 mg kg-1 for dentifrices and 
90–450 mg kg-1 for mouth rinses) are of particular 
interest for future development. The high efficacy of F
-
 
in inhibiting the development of caries owes its origins 
to the capability of this ion to substitute for -OH groups 
in HA, Ca
10
(PO
4
)
6
(OH)
2
. This results in the formation 
of partially or fully fluoridated apatitic phases, 
Ca
10
(PO
4
)
6
F
x
(OH)
2-x
, whose resistance to acid-mediated 
dissolution is much greater than that of the precursor 
non-fluoridated apatite.
(144)
 Remineralisation of early 
caries lesions is also promoted by F
-
 through mineral 
uptake encouragement at the less soluble fluoridated 
apatitic phase. 
The substitution (full or partial) of the OH
-
 lattice 
position by F
-
 improves the resistance of the enamel to 
demineralisation; this is reflected by a reduction in the 
critical demineralisation pH of FHAP (dissolves at pH 
4.5) as compared to HA (pH 5.5).
(145,146)
 F
-
 makes 
apatite crystals less soluble in acid by two mechanisms. 
In FHAP, F
-
 ions form strong hydrogen bonds with 
neighbouring OH
-
 ions, making FHAP crystals more 
resistant to dissolution than either HA or 
fluorapatite;
(147)
 this occurs in competition with other 
ion impurities (those of Mg, Na, Se, CO3
2-
, acid 
phosphate), which are known to increase the solubility 
of HA crystals [144]. Also, F
-
 incorporation increases 
the packing density and quality of the crystalline 
lattice;
(148)
 FHAP crystals have fewer imperfections 
than HA crystals – due to the slightly smaller size of F- 
(1.32 Å) relative to that of OH
-
 (1.68 Å) – with the 
implication that fluorapatite and FHAP crystals are less 
accessible to the solubilising medium than HA crystals. 
However, the presence of carious lesions on shark 
enamel (which consists of solid fluorapatite)
(149)
 
highlights the need for further investigations into the 
mode of action of fluoride. 
In addition to the tooth-strengthening effects of F
-
, 
there has been the suggestion that the same agent may 
offer a subtle antimicrobial benefit.
(150)
 Kamotsay et al. 
suggested that high concentrations of NaF slow down 
the multiplication of cariogenic oral bacteria and 
fungi.
(151)
 Clinch, in his review of the effects of F
-
 on 
oral bacteria, states that ‘although in vitro studies 
suggest that F
-
 may have anti-microbial effects, the in 
vivo evidence using F
-
 concentrations commonly used 
in toothpastes (500 – 1500 ppm; with subsequent 
mouth-rinsing with water) fails to demonstrate any 
clinically significant antagonistic effect on the bacteria 
involved in cariogenic activity’. In fact, no available 
research has shown that F
-
 at 1 ppm in water 
significantly alters plaque metabolism or plaque growth 
(bactericidal effects).
(152)
 
The efficacy of F
-
 has been related to concentration 
and pH, while the formation of a CaF2 reservoir may 
also be of significance.
(37)
 While the erosion and caries 
prevention properties of compounds such as NaF, 
amine fluoride (AmF), stannous fluoride (SF) and 
acidulated phosphate fluoride (APF) are well 
documented, tetrafluorides have been highlighted as 
agents worthy of further investigation. In their study of 
polyvalent metals, McCann et al.
(153)
 identified TiF4 as 
a candidate compound for clinical and epidemiological 
studies: TiF4 is thought to synergise the effect of F
-
 
through the formation of a surface layer with increased 
mechanical strength.
(154)
 Complementary work by Hove 
et al.
(155)
 and others
(156-160)
 further support the notion of 
an acid-resistant surface layer. The potential benefits of 
formulations for the controlled release of F
-
 may also be 
worthy of investigation.
(8)
 
 
Casein 
Of considerable interest in the prevention of tooth 
erosion is casein, a phosphoprotein found in bovine 
milk. Casein phosphopeptides (CPP; -Ser (P)-Ser (P)-
Ser (P)-Glu-Glu),
(161)
 that may be formed from the 
tryptic digestion of casein, solubilise minerals, 
especially those of Ca
2+
, by forming amorphous 
phosphate nanocluster complexes (CPP-ACP),
(162)
 that 
prevent its growth to the critical size necessary for 
nucleation, phase transformation and 
precipitation.
(163,164)
 Rose et al.
(165)
 showed CPP-ACP to 
bind well to dental plaque, which they suggested 
provides a large Ca
2+
 reservoir that assists 
remineralisation and also acts as a barrier to 
demineralisation. There is evidence that CPP-ACP 
inhibits demineralisation by sports drinks,
(166)
 soft 
drinks,
(167)
 and confections.
(168)
 Synergistic interactions 
with co-formulated F
-
 
(169,170)
 have been shown to 
augment these effects further. Stable and highly soluble 
CPP-ACP has been trademarked as Recaldent™.(8) 
Several paste formulations are available, such as Tooth 
Mousse™ (GC International Tokyo, Japan), Topacal C-
5 (NSI Dental, Hornsby, Australia) and MI Paste Plus 
(GC International) .
(164) 
 
Strategies for treating dentin hypersensitivity 
In addition to the zero tolerance towards adverse 
effects, the performance demands of modern 
hypersensitivity treatments are determined by the 
requirement for a rapid onset of action.
(171)
 The 
treatment of DH is now integral to many dentifrices, 
though the incorporation of technologies designed to 
prevent the induction of pain either through the 
inactivation of nerve responses or by the prevention of 
the movement of liquid within dental tubules.
(172)
 
 
Potassium ions 
Potassium ions (in the form of citrates, NO3
-
, 
oxalates and Cl
-
) are known to inhibit DH by 
inactivating nerve responses though the sustained 
depolarisation of the nerve-fibre membrane.
(173-175)
 
KNO3, which has FDA approval, has found wide 
use
(176)
 even though its mechanism of action is not fully 
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understood. Apart from the desensitising effect of 
K
+
,
(177)
 it has been suggested that complementary 
oxidising effects and the blocking of tubules by 
crystallisation may be of significance.
(171,178)
 
 
Oxalates 
Oxalates were first proposed as agents for the 
treatment of DH in the late 1970s, by which time 
numerous studies had suggested their effectiveness at 
inhibiting hydraulitic conductance by the blocking of 
dentinal fluid flow as a result of the soluble potassium 
oxalate converting to insoluble calcium oxalate within 
the tubules.
(179-181)
 More recent work, however, appears 
to suggest than monohydrogen monopotassium oxalate 
is the only efficacious potassium oxalate for the 
treatment of DH.
(182-185)
 
 
Fluorides 
Stannous fluoride (SF) has been shown to be 
effective not only in the prevention of dental caries,
(187)
 
but also in the reduction of DH.
(187-189)
 This agent acts 
by effecting a decrease in dentinal permeability through 
the precipitation of CaF2 crystals in the tubules.
(190)
 
However, SF has been associated with extrinsic 
staining. Attempts to address this issue through re-
formulation
(191)
 have seen SF being used in conjunction 
with KNO3
(192)
 and sodium hexametaphosphate.
(193,194)
 
A dentifrice containing SF and NaF has shown to 
generate in situ, during tooth brushing, an SF complex 
that does not cause staining.
(191,195)
 It has been claimed 
that the formulation offers a multitude of oral-care 
benefits, namely: anti-caries potential, plaque reduction, 
hypersensitivity inhibition, extrinsic stain prevention, 
and improved breath malodour.
(196)
 
 
Calcium phosphate precipitation 
The in vitro capacity of calcium phosphate 
precipitation to effect dental-tubule occlusion appears 
to owe its origins to the pH sensitivity of the aqueous 
solubility of calcium phosphate: experiments have 
shown that a two-step procedure, in which dentin is 
saturated with disodium phosphate (5%) and then 
treated with CaCl2 (10%), induces the deposition of 
calcium phosphate in the tubules and on the dentin 
surface.
(197)
 The synergistic effect of NaF has also been 
investigated, with the conclusion that its presence leads 
to more apatitic precipitation formation.
(198)
 
Bioactive glasses 
Rationalised by the principle that silica can act as a 
nucleation site for precipitation of calcium and 
phosphorus, dental-tubule occlusion through the use of 
bioactive glasses has also received some attention as is 
exemplified by published work on biosilicates
(199,200)
 
and the FDA approval of the NovaMin anti-
hypersensitivity treatment.
(201)
 The active ingredient of 
NovaMin is calcium sodium phosphosilicate (CSPS), 
which on exposure to aqueous media liberates Ca
2+
 and 
phosphorus ions that re-form into hydroxy-carbonate 
apatite.
(201)
 In vitro experiments by Burwell et al.
(202)
 
have shown that the formed mineralised layer of 
hydroxy-carbonate apatite is mechanically strong and 
resistant to acid challenges. 
 
Further materials and techniques 
Studies have shown that a technology that affects 
the sealing of dentin tubules with an acid resistant plug 
that contains arginine, CaCO3 and phosphate is 
effective at relieving DH.
(203,204)
 This finding has led to 
the design of a dentifrice, Pro-Argin™ and its 
whitening variant, which are claimed to offer instant 
relief to DH-induced pain .
(203,205)
 The performance of 
arginine-containing pastes has been the subject of a 
comparative study involving Sr formulations. Both 
strontium acetate and SrCl2 have been shown to form 
mineralised deposits within dentinal tubules and on the 
surface of exposed dentin, with the acetate salt 
exhibiting clinically proven effectiveness.
(206,207)
 Other 
approaches towards increased dental-tubule occlusion 
have included NaF treatment in conjunction with 
iontophoresis,
(208,209)
 or with erbium-doped yttrium 
aluminium garnet (Er:Y3Al5O12; Er:YAG),
(210)
 or 
neodymium-doped YAG (Nd:YAG)
(211)
 laser 
irradiation. 
 
State of the art and future direction 
Despite significant advances in anti-
hypersensitivity, remineralisation and tooth-whitening 
technologies, the long-standing challenge of plaque 
control remains central to improved dental care. Linked 
to this is the increasing prevalence of dental erosion, 
particularly amongst the young. A possible alternative 
to the use of antimicrobials to control plaque is to 
employ non-toxic, anti-adhesion polymers that form a 
thin protective coating onto the tooth surface. 
Complicated by the rapid formation of the salivary 
pellicle, the major challenge is to design the delivery 
system (toothpaste or mouth rinse) such that the 
polymer is deposited as a thin but substantive coating 
on the tooth surface. A key issue with conventional 
occlusive technologies that use inorganic salts, such as 
amorphous calcium phosphate, is the susceptibility of 
the precipitated mineral to acid attack, which impacts 
upon substantivity. The blocking of the tubule lumen by 
calcium oxalate or silica gives a longer-lasting benefit, 
but the use of polymer thin films provides an 
opportunity not only to treat existing DH, but also to 
help prevent its occurrence by laying down a shield that 
protects against acid erosion and the action of tooth 
chromogens. Aqueous nanoparticulate suspensions of 
the 2:1 copolymer of 1H,1H,2H,2H-perfluorodecyl 
acrylate and 2-hydroxyethyl acrylate have been shown 
to form into substantive dental coatings that offer 
significant resistance to staining, to bacterial 
colonisation and to demineralisation, and also to inhibit 
the dentinal fluid flow that provides the pain stimulus 
of dental hypersensitivity (Fig. 7).
(212,213)
 The 
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prohibitive production cost for this material has 
provided the impetus for current research activities on, 
amongst other readily accessible materials, aqueous 
latexes of the poly(alkyl methacrylate)s. While the 
potential utility of one such material, poly(butyl 
methacrylate), to be deposited as a substantive tooth 
coating
(215)
 that offers protection against dental staining, 
dentinal hypersensitivity and acid 
demineralisation
(216,217)
 has been shown, its plaque-
inhibition properties remain to be tested. 
 
 
Fig. 7: Low-surface-energy polymers: (a) 
1H,1H,2H,2H-perfluoroalkyl acrylates, (b) 
1H,1H,2H,2H-perfluoroalkyl methacrylates and (c) 
1H,1H,2H,2H-perfluoroalkylacrylate 
(methacrylate)-co-2-hydroxyethyl acrylate 
(methacrylate); n = 2, 3, 7; R, R = H / CH3. Adapted 
from 
(212)
 and used with permission. 
 
Dedication 
We dedicate this work to Dr Thomas G. Nevell 
who sadly passed away shortly after the completion of 
the project from which this review originated. 
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ACP  amorphous calcium phosphate 
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CHX  chlorhexidine 
DDA  N,N-dimethyldodecylammonium 
DH  dentin sensitivity 
DLVO Derjaguin and Landau, Verwey and 
Overbeek 
EPS  exopolysaccharide 
FDA  Food and Drug Administration 
FHAP  fluorohydroxyapatite 
HA  hydroxyapatite 
HEX  hexetidine 
MMP  matrix metalloproteinase 
OCP  octacalcium phosphate 
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iodide) 
PBS  phosphate buffered saline 
PEG  poly(ethylene glycol) 
PMOX  poly(2-methyl-2-oxazoline) 
PS  poly(styrene) 
SEM   scanning electron microscopy 
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SF  stannous fluoride 
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YAG  yttrium aluminium garnet 
 
